Biochemistry, Genetics and Molecular Biology
Allele
62%
Autophagy
50%
C-Terminus
25%
Cancer Cell
53%
Catenin
50%
Chromosome 1
25%
Cytogenetics
50%
Downregulation
26%
Flow Cytometry
31%
Fluorescence Microscope
25%
G Protein
50%
Gene Activation
50%
Gene Product
81%
Genetic Determinism
50%
Genetic Divergence
50%
Hematopoietic Stem Cell
50%
Human Immunodeficiency Virus
50%
Human Leukocyte Antigen
50%
in Situ Hybridization
50%
Induced Pluripotent Stem Cell
50%
Meiosis
25%
Methylation
56%
Microarrays
50%
Microsatellite DNA
50%
Molecular Weight
50%
Mouse
75%
Multidrug Resistance
100%
Multigene Family
50%
Myeloid
56%
Non-Allelic Homologous Recombination
25%
Oncogene
56%
Phosphoinositide 3-Kinase
50%
Progeny
50%
Promoter Region
62%
Protease
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Representational Difference Analysis
31%
Serine
50%
Serine Protease
75%
Smoking
44%
Spermatogenesis
50%
Staining
25%
Stem Cell
45%
Supernumerary Chromosome
50%
Telomere
50%
Telomere
50%
Threonine
58%
Transgene
50%
Upregulation
75%
Western Blot
25%
Keyphrases
Adult T-cell Leukemia
50%
Anticancer Drugs
16%
Authentication Patterns
50%
Behavioral Factors
50%
Breast Cancer Epithelial Cells
50%
Chromosome Counting
25%
Chromosome Karyotyping
25%
Contrast Difference
25%
DNA Fragments
16%
Dp(16)1Yey
20%
Evolutionary Breakpoints
16%
Ex-smokers
27%
Experimental Reproducibility
25%
Fire Department
50%
Flow Cytometry
16%
Gene Family
50%
Genetic Factors
50%
Genetic Variants
50%
Gonadotrope Cell Lines
50%
Human Resilience
25%
Human Testis
60%
Local Hotspot
16%
MCF-7
62%
Methyl Salicylate (MeSA)
16%
Morphological Appearance
25%
Multidrug Resistance
50%
Multidrug-resistant
25%
New York City
55%
Nuclei Area
25%
Oncolytic Virotherapy
50%
People Living with HIV (PLHIV)
50%
Pituitary Gonadotropes
50%
Protease
50%
Pulsatile GnRH Therapy
25%
Rab6
60%
Representational Similarity Analysis
16%
Rictor
50%
Sarcoidosis
50%
Sarcoma Cells
16%
Short Tandem Repeat Profiling
25%
Single-cell Analysis
50%
Smoke Cigarette
50%
Smokers
16%
Talimogene Laherparepvec (T-VEC)
50%
Testis-specific
50%
Transition Mechanism
50%
TSP50
100%
Uterine Sarcoma
16%
World Trade Center
50%
WTH3
100%
Medicine and Dentistry
Adult T-Cell Leukemia/Lymphoma
50%
Adverse Effect
10%
Allele
13%
Autophagy
50%
Cancer
16%
Cancer Cell
10%
Cancer Growth
10%
Catheter Ablation
10%
CD8 Antigen
10%
Cell Function
6%
Chromosome 1
9%
Chromosome 6
9%
Disease Exacerbation
10%
DNA Fragment
25%
Drug Accumulation
25%
Genetic Variability
50%
Hematopoietic Stem Cell
50%
Human Leukocyte Antigen
18%
Human T-Lymphotropic Virus 1
10%
Identified Patient
10%
Immune Response
29%
Immunotherapy
20%
In Vitro
10%
Lung Adenocarcinoma
10%
Lung Cancer
50%
Macrophage
10%
Mammalian Target of Rapamycin
10%
Melanoma
10%
Memory T Cell
10%
Methylation
25%
Multigene Family
50%
Myelodysplastic Syndrome
50%
Neoplasm
20%
Oncolytic Virotherapy
50%
Phosphoinositide 3-Kinase
50%
Radiation Therapy
10%
Recurrence Risk
10%
Representational Difference Analysis
25%
Sarcoidosis
50%
Sarcoma Cell Line
25%
Smoking
10%
T Cell
10%
Talimogene Laherparepvec
50%
Targeted Therapy
10%
The Cancer Genome Atlas
10%
Tumor Necrosis
10%
Tumor Regression
10%
Uterus Sarcoma
25%
Vinblastine
25%
Virotherapy
10%
